Showing results (351-360 of 556) with videos related to
Sort By:
Pageof 56
Clinical Pharmacokinetics|March 1, 2008
Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairmentSarah M McCabe, Qing Ma, Judianne C Slish, et al.Southern African Journal of HIV Medicine|March 12, 2020
Perspectives on oral pre-exposure prophylaxis use amongst female sex workers in Harare, ZimbabweTinashe Mudzviti, Anesu Dhliwayo, Byrone Chingombe, et al.Transplantation Proceedings|June 4, 2013
Influence of ureteric anastomosis technique on urological complications after kidney transplantationA Raman, S Lam, A Vasilaras, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 22, 2012
Inferior early posttransplant outcomes for recipients of right versus left deceased donor kidneys: an ANZDATA registry analysisH Vacher-Coponat, S McDonald, P Clayton, et al.Prostate Cancer and Prostatic Diseases|February 3, 2005
Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancerP M Rovito, P D Morse, K Spinek, et al.Biopharmaceutics & Drug Disposition|November 29, 2007
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteersQing Ma, Alan Forrest, Susan L Rosenkranz, et al.Journal of Pharmaceutical and Biomedical Analysis|July 3, 2007
Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometryRobin DiFrancesco, Robert DiCenzo, Glorimar Vicente, et al.Drugs in R&D|September 7, 2017
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sJennifer J Kiser, Darlene Lu, Susan L Rosenkranz, et al.The Annals of Thoracic Surgery|July 1, 1991
Permanent transfemoral pacemaker insertion after repair of congenital heart diseaseG W Laub, A H Olivencia-Yurvati, S Muralidharan, et al.Antimicrobial Agents and Chemotherapy|January 1, 1997
Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infectionG D Morse, M A Fischl, M J Shelton, et al.Pageof 56